Michael L. Linenberger

TL;DR: The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.

TL;DR: This Sixth Edition of the ASFA Special Issue has further improved the process of using evidence‐based medicine in the recommendations by consistently applying the category and GRADE system definitions, but eliminating the “level of evidence” criteria.

TL;DR: Genotyping for factor XIIIA Val34Leu, Tyr204Phe and Pro564Leu was performed in a population‐based study of myocardial infarction (MI) and ischaemic stroke among white women < 45‐years of age and 345 demographically similar controls, and potential interactions with other risk factors were examined.

TL;DR: The American Society for Apheresis Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice and assigned selected diseases to one of five categories ( category I, II, III, IV, and P).

TL;DR: It is concluded that exchange transfusion (ET) is not indicated in the setting of severe malaria, and the effect of ET on mortality cannot be reliably judged in the absence of this pathobiological correlate.